Judy Sibayan

2.7k total citations
21 papers, 418 citations indexed

About

Judy Sibayan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Judy Sibayan has authored 21 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 7 papers in Genetics. Recurrent topics in Judy Sibayan's work include Diabetes Management and Research (19 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (10 papers) and Diabetes and associated disorders (7 papers). Judy Sibayan is often cited by papers focused on Diabetes Management and Research (19 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (10 papers) and Diabetes and associated disorders (7 papers). Judy Sibayan collaborates with scholars based in United States, United Kingdom and Israel. Judy Sibayan's co-authors include Peter Calhoun, Roy W. Beck, Craig Kollman, Bruce A. Buckingham, Fraser Cameron, David M. Maahs, B. Wayne Bequette, John W. Lum, H. Peter Chase and Darrell M. Wilson and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Judy Sibayan

17 papers receiving 409 citations

Peers

Judy Sibayan
Barbora Paldus Australia
K Remus Germany
Yongjin Xu United States
Jonathan Burdick United States
Renee A. Meier New Zealand
Judy Sibayan
Citations per year, relative to Judy Sibayan Judy Sibayan (= 1×) peers G Faber-Heinemann

Countries citing papers authored by Judy Sibayan

Since Specialization
Citations

This map shows the geographic impact of Judy Sibayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Sibayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Sibayan more than expected).

Fields of papers citing papers by Judy Sibayan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy Sibayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Sibayan. The network helps show where Judy Sibayan may publish in the future.

Co-authorship network of co-authors of Judy Sibayan

This figure shows the co-authorship network connecting the top 25 collaborators of Judy Sibayan. A scholar is included among the top collaborators of Judy Sibayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy Sibayan. Judy Sibayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calhoun, Peter, et al.. (2025). Real-World Clinical Impact of Using Personal Glucose Targets in a Hybrid Closed-Loop System Differs According to Age. Diabetes Technology & Therapeutics. 28(2). 167–174.
2.
Pasquel, Francisco J., Hou-Hsien Chiang, Dori Khakpour, et al.. (2025). Accuracy of Dexcom G6 Pro Continuous Glucose Monitor in the Intensive Care Setting: TIGHT ICU G6 Study. Diabetes Technology & Therapeutics. 28(1). 10–17.
3.
Lee, Tara, Corinne Collett, Sara Hartnell, et al.. (2025). Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study. The Lancet Diabetes & Endocrinology. 13(3). 210–220. 2 indexed citations
4.
Chiang, Hou-Hsien, Dori Khakpour, Irl B. Hirsch, et al.. (2025). Dexcom G7 Accuracy and Reproducibility in the Intensive Care Unit. Diabetes Technology & Therapeutics. 27(9). 747–752. 1 indexed citations
5.
Carlson, Anders L., Roy W. Beck, Zoey Li, et al.. (2025). Continuous Glucose Monitoring-Measured Glucose Levels During Oral Glucose Tolerance Testing in Pregnancy. Diabetes Technology & Therapeutics. 27(6). 439–448. 2 indexed citations
6.
Boughton, Charlotte K., Janet M. Allen, Julia Ware, et al.. (2024). The effect of closed-loop glucose control on C-peptide secretion in youth with newly diagnosed type 1 diabetes: the CLOuD RCT. SHILAP Revista de lepidopterología. 1–75.
7.
Li, Zoey, Roy W. Beck, Celeste Durnwald, et al.. (2024). Continuous Glucose Monitoring Prediction of Gestational Diabetes Mellitus and Perinatal Complications. Diabetes Technology & Therapeutics. 26(11). 787–796. 3 indexed citations
8.
Calhoun, Peter, Judy Sibayan, Yue Ruan, et al.. (2024). Safety of Options to “Boost” (Enhancing Insulin Infusion Rates) and “Ease-Off” (Reducing Insulin Infusion Rates) in CamAPS FX Hybrid Closed-Loop System: A Real-World Analysis. Diabetes Technology & Therapeutics. 27(1). 60–65. 3 indexed citations
9.
Durnwald, Celeste, Roy W. Beck, Zoey Li, et al.. (2024). Continuous Glucose Monitoring–Derived Differences in Pregnancies With and Without Adverse Perinatal Outcomes. Obstetrics and Gynecology. 144(5). 684–696. 4 indexed citations
10.
Durnwald, Celeste, Roy W. Beck, Zoey Li, et al.. (2024). Continuous Glucose Monitoring Profiles in Pregnancies With and Without Gestational Diabetes Mellitus. Diabetes Care. 47(8). 1333–1341. 28 indexed citations
11.
Carlson, Anders L., Roy W. Beck, Zoey Li, et al.. (2024). Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies. BMJ Open Diabetes Research & Care. 12(3). e003989–e003989. 12 indexed citations
12.
Madrid‐Valero, Juan J., Julia Ware, Janet M. Allen, et al.. (2023). Sleep Quality and Quantity in Caregivers of Children with Type 1 Diabetes Using Closed-Loop Insulin Delivery or a Sensor-Augmented Pump. Pediatric Diabetes. 2023. 1–10. 1 indexed citations
13.
Davis, Georgia M., Michael S. Hughes, Sue A. Brown, et al.. (2023). Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial. Diabetes Technology & Therapeutics. 25(10). 677–688. 19 indexed citations
14.
Boughton, Charlotte K., Janet M. Allen, Julia Ware, et al.. (2022). Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes. New England Journal of Medicine. 387(10). 882–893. 57 indexed citations
15.
Dovč, Klemen, Tadej Battelino, Roy W. Beck, et al.. (2022). Impact of Temporary Glycemic Target Use in the Hybrid and Advanced Hybrid Closed-Loop Systems. Diabetes Technology & Therapeutics. 24(11). 848–852. 6 indexed citations
16.
Hood, Korey K., Lori M. Laffel, Thomas Danne, et al.. (2021). Lived Experience of Advanced Hybrid Closed-Loop Versus Hybrid Closed-Loop: Patient-Reported Outcomes and Perspectives. Diabetes Technology & Therapeutics. 23(12). 857–861. 45 indexed citations
17.
Boughton, Charlotte K., Sara Hartnell, Hood Thabit, et al.. (2021). Hybrid closed‐loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double‐blind, multicentre, multinational, randomized, crossover study. Diabetes Obesity and Metabolism. 23(6). 1389–1396. 59 indexed citations
18.
Tauschmann, Martin, Janet M. Allen, Sara Hartnell, et al.. (2019). Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Yearbook of pediatric endocrinology. 9 indexed citations
19.
Buckingham, Bruce A., Dan Raghinaru, Fraser Cameron, et al.. (2015). Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care. 38(7). 1197–1204. 92 indexed citations
20.
Buckingham, Bruce A., Fraser Cameron, Peter Calhoun, et al.. (2013). Outpatient Safety Assessment of an In-Home Predictive Low-Glucose Suspend System with Type 1 Diabetes Subjects at Elevated Risk of Nocturnal Hypoglycemia. Diabetes Technology & Therapeutics. 15(8). 622–627. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026